Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)

Carla L. Alves; Sidse Ehmsen; Mikkel G. Terp; Neil Portman; Martina Tuttolomondo; Odd L. Gammelgaard; Monique F. Hundebøl; Kamila Kaminska; Lene E. Johansen; Martin Bak; Gabriella Honeth; Ana Bosch; Elgene Lim; Henrik J. Ditzel

doi:10.1038/s41467-021-25901-z

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)

Carla L. Alves^*, Sidse Ehmsen, Mikkel G. Terp, Neil Portman, Martina Tuttolomondo, Odd L. Gammelgaard, Monique F. Hundebøl, Kamila Kaminska, Lene E. Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik J. Ditzel

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

27 Downloads (Pure)

Abstract

The original HTML version of this Article was updated shortly after publication because the previous HTML version linked to an incorrect Transparent Peer Review file.

Originalsprog	Engelsk
Artikelnummer	5588
Tidsskrift	Nature Communications
Vol/bind	12
Antal sider	1
ISSN	2041-1723
DOI	https://doi.org/10.1038/s41467-021-25901-z
Status	Udgivet - 16. sep. 2021

Bibliografisk note

Publisher Copyright:
© 2021, The Author(s).

Dokumenter og links

10.1038/s41467-021-25901-zLicens: CC BY

Open Access VersionForlagets udgivne version, 435 KBLicens: CC BY

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Fingeraftryk

Dyk ned i forskningsemnerne om 'Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Alves, C. L., Ehmsen, S., Terp, M. G., Portman, N., Tuttolomondo, M., Gammelgaard, O. L., Hundebøl, M. F., Kaminska, K., Johansen, L. E., Bak, M., Honeth, G., Bosch, A., Lim, E., & Ditzel, H. J. (2021). Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9). Nature Communications, 12, Artikel 5588. https://doi.org/10.1038/s41467-021-25901-z

@article{286977a2bf68450ba6eccf4e8124a278,

title = "Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)",

abstract = "The original HTML version of this Article was updated shortly after publication because the previous HTML version linked to an incorrect Transparent Peer Review file.",

author = "Alves, {Carla L.} and Sidse Ehmsen and Terp, {Mikkel G.} and Neil Portman and Martina Tuttolomondo and Gammelgaard, {Odd L.} and Hundeb{\o}l, {Monique F.} and Kamila Kaminska and Johansen, {Lene E.} and Martin Bak and Gabriella Honeth and Ana Bosch and Elgene Lim and Ditzel, {Henrik J.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = sep,

day = "16",

doi = "10.1038/s41467-021-25901-z",

language = "English",

volume = "12",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

}

Alves, CL , Ehmsen, S , Terp, MG, Portman, N, Tuttolomondo, M , Gammelgaard, OL, Hundebøl, MF, Kaminska, K, Johansen, LE, Bak, M, Honeth, G, Bosch, A, Lim, E & Ditzel, HJ 2021, 'Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)', Nature Communications, bind 12, 5588. https://doi.org/10.1038/s41467-021-25901-z

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9). / Alves, Carla L.; Ehmsen, Sidse ; Terp, Mikkel G. et al.
I: Nature Communications, Bind 12, 5588, 16.09.2021.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Publisher Correction

T2 - Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)

AU - Alves, Carla L.

AU - Ehmsen, Sidse

AU - Terp, Mikkel G.

AU - Portman, Neil

AU - Tuttolomondo, Martina

AU - Gammelgaard, Odd L.

AU - Hundebøl, Monique F.

AU - Kaminska, Kamila

AU - Johansen, Lene E.

AU - Bak, Martin

AU - Honeth, Gabriella

AU - Bosch, Ana

AU - Lim, Elgene

AU - Ditzel, Henrik J.

PY - 2021/9/16

Y1 - 2021/9/16

N2 - The original HTML version of this Article was updated shortly after publication because the previous HTML version linked to an incorrect Transparent Peer Review file.

AB - The original HTML version of this Article was updated shortly after publication because the previous HTML version linked to an incorrect Transparent Peer Review file.

U2 - 10.1038/s41467-021-25901-z

DO - 10.1038/s41467-021-25901-z

M3 - Comment/debate

C2 - 34531405

AN - SCOPUS:85115390408

SN - 2041-1723

VL - 12

JO - Nature Communications

JF - Nature Communications

M1 - 5588

ER -

Alves CL , Ehmsen S , Terp MG, Portman N, Tuttolomondo M , Gammelgaard OL et al. Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9). Nature Communications. 2021 sep. 16;12:5588. Epub 2021 sep. 16. doi: 10.1038/s41467-021-25901-z